Wisconsin Infant Study Cohort (WISC)
Wisconsin Infant Study Cohort (WISC)
批准号:
10091393
负责人:
James E. Gern
金额:
$67.32万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2023-01-31
关键词:
1 year oldAddressAffectAgeAllergensAllergicAllergic DiseaseAmishAnti-Inflammatory AgentsAntiviral AgentsAntiviral ResponseAtopic DermatitisBacteriaBirthBlood CellsCell MaturationCell physiologyCellsChildChildhoodClinicalCohort StudiesCommunitiesCountryDendritic CellsDevelopmentDiagnosticDiseaseEnrollmentEnvironmental ExposureEnvironmental Risk FactorEpithelialEpithelial CellsExhibitsExposure toFamilyFarming CommunityFarming environmentFecesGene ExpressionHealthHomeHouse DustHouseholdHypersensitivityIgEImmuneImmune responseImmune systemIndianaInfantInfectionInflammatoryInflammatory ResponseInterventionLifeLivestockLongitudinal StudiesLung diseasesMeasuresMedicineMetagenomicsMicrobeMonitorMononuclearMorbidity - disease rateMucous MembraneNasopharynxNewborn InfantOutcomeParticipantPathway interactionsPatternPhenotypePilot ProjectsPreventionPrimary PreventionQuestionnairesRegulatory T-LymphocyteReportingRhinovirusRiskSamplingSeveritiesSeverity of illnessShapesSocietiesSurveysTNF geneTechnologyTestingTrustUmbilical Cord BloodViralViral Load resultViral Respiratory Tract InfectionVirusWhole BloodWisconsinWorkairborne allergenburden of illnesscohortcostcytokineearly childhoodenvironmental allergenexperiencefungushutteriteimmune functionimprovedin silicoinnate immune functionlifestyle factorslongitudinal analysismicrobialmicrobial colonizationmicrobial genomicsmicrobiotamonocyteneutrophilnovelnovel strategiespostnatalrecruitrespiratoryrespiratory healthresponsevirology
中文摘要
项目总结/摘要
儿童病毒性呼吸道疾病(VRI)的发病率和社会成本是惊人的,
呼吸道疾病猖獗。在寻求预防这些常见和重要疾病的过程中,
也许解决办法就在农场。威斯康星州婴儿研究队列(WISC)的初步结果
研究表明,在农场长大的儿童VRI和特应性皮炎减少,
生命早期的细胞成熟轨迹。此外,在我们的初步研究中,
新生儿(高微生物暴露,低过敏率)具有更成熟的表型,
与WISC新生儿相比。总的来说,这些发现支持了我们的中心假设:农场-
相关的微生物暴露与免疫细胞成熟的增加、病毒感染的减少、
呼吸道疾病的严重程度,并降低过敏性。为了解决这个假设,我们将招募
我们目前招募了204名WISC参与者(93名农场参与者,111名非农场参与者),并招募了额外的Amish,WISC农场,
和WISC非农业家庭(50/组)。我们的研究有三个目标,采用尖端技术,
利用我们的调查团队在农业医学、出生队列、呼吸道病毒学方面的丰富经验,
和儿童的免疫发育。目的1:描述与农场相关的暴露与免疫相关性的关系
早期生活的发展。我们假设,农场相关的微生物暴露将促使先天性
免疫细胞在生命早期的成熟和功能,包括增强的抗炎机制。在这些
研究,我们将确定农业和微生物对免疫发育的关键细胞(上皮细胞,
浆细胞样树突状细胞、中性粒细胞、T调节细胞)在粘膜对病毒和过敏原的反应中起作用。
目的2:确定农场暴露如何影响VRI的负担和过敏性疾病的发病率。我们
假设接触农场的婴儿减少了VRI负担并降低了对常见病毒的敏感性
环境过敏原在这些研究中,我们将使用病毒诊断来确定感染和疾病,
并测量对空气过敏原的特异性IgE。目标3:确定与农场有关的
环境和生活方式因素,微生物暴露和定植(鼻咽和粪便),免疫
发展和临床结局(呼吸系统疾病负担和AD和过敏性致敏的发生率)。我们
假设来自农场家庭,特别是阿米什家庭房屋灰尘具有更多样的环境
微生物群落,鼻咽和肠道的微生物定植更多样化,
呼吸系统健康结果。在这些研究中,微生物基因组学将被用于识别细菌和真菌,
家庭灰尘,鼻咽和肠道样本,我们将分析与免疫模式的关系。
发育、VRI和过敏。这些研究的完成将导致开发新的战略,
增强生命早期的免疫发育,以实现VRI和过敏性疾病的一级预防。
英文摘要
PROJECT SUMMARY/ABSTRACT
The morbidity and cost to society from childhood viral respiratory illnesses (VRI) is staggering, and allergic
respiratory disease is rampant. In the search for prevention for these common and important diseases,
perhaps the solutions are on the farm. Preliminary results from the Wisconsin Infant Study Cohort (WISC)
demonstrate that children raised on farms have reduced VRI and atopic dermatitis, and distinct innate immune
cell maturation trajectories in early life. Furthermore, in our preliminary studies mononuclear cells from Amish
newborns (high microbial exposure, low rates of allergy) had a more mature phenotype and enhanced antiviral
responses compared to WISC newborns. Collectively, these findings support our central hypothesis: farm-
related microbial exposures are associated with increased immune cell maturation, decreased viral
respiratory illness severity, and decreased allergic sensitization. To address this hypothesis, we will enlist
our currently enrolled 204 WISC participants (93 farm, 111 non-farm), and enroll additional Amish, WISC farm,
and WISC non-farm families (50/group). Our study has three aims that employ cutting-edge technologies and
leverage our investigative team's extensive experience with farm medicine, birth cohorts, respiratory virology
and immune development in children. Aim 1: To characterize how farm-related exposures relate to immune
development in early life. We hypothesize that farm-related microbial exposures will prompt increased innate
immune cell maturation and function in early life, including enhanced anti-inflammatory mechanisms. In these
studies, we will identify farming and microbial effects on immune development of key cells (epithelial cell,
plasmacytoid dendritic cell, neutrophil, Tregulatory cells) in the mucosal response to viruses and allergens.
Aim 2: To determine how farm exposures affect the burden of VRI and rates of allergic diseases. We
hypothesize that farm-exposed infants have reduced VRI burden and reduced sensitization to common
environmental allergens. In these studies, we will use viral diagnostics to determine infections and illnesses,
and measure specific IgE to aeroallergens. Aim 3: To define group-specific associations between farm-related
environmental and lifestyle factors, microbial exposure and colonization (nasopharyngeal and stool), immune
development, and clinical outcomes (respiratory illness burden and rates of AD and allergic sensitization). We
hypothesize that house dust from farm homes, particularly Amish households, has more diverse environmental
microbiota communities, more diverse microbial colonization of the nasopharynx and gut, and improved
respiratory health outcomes. In these studies, microbial genomics will be used to identify bacteria and fungi in
household dust, nasopharynx, and gut samples, and we will analyze relationships with patterns of immune
development, VRI, and allergy. Completion of these studies will lead to development of novel strategies for
enhancing immune development in early life to achieve primary prevention of VRI and allergic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center
-
批准号:10209602
-
项目类别:
-
资助金额:$695.27万
-
财政年份:2021
-
负责人:James E. Gern
-
依托单位:
Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center
-
批准号:10608089
-
项目类别:
-
资助金额:$676.71万
-
财政年份:2021
-
负责人:James E. Gern
-
依托单位:
Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center
-
批准号:10391566
-
项目类别:
-
资助金额:$665.07万
-
财政年份:2021
-
负责人:James E. Gern
-
依托单位:
Identifying Coronavirus B-cell Epitopes Associated with COVID-19 Illness Severity
-
批准号:10170660
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2020
-
负责人:James E. Gern
-
依托单位:
Human epidemiology and response to SARS-CoV-2 (HEROS)
-
批准号:10230381
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2020
-
负责人:James E. Gern
-
依托单位:
Viral and Environmental Determinants of Rhinovirus Illness Severity
-
批准号:10397758
-
项目类别:
-
资助金额:$12.21万
-
财政年份:2020
-
负责人:James E. Gern
-
依托单位:
Viral and Environmental Determinants of Rhinovirus Illness Severity
-
批准号:10265713
-
项目类别:
-
资助金额:$40.35万
-
财政年份:2020
-
负责人:James E. Gern
-
依托单位:
Wisconsin Infant Study Cohort (WISC) ECHO Pediatric Follow-Up
-
批准号:10744843
-
项目类别:
-
资助金额:$67.89万
-
财政年份:2016
-
负责人:James E. Gern
-
依托单位:
Children's Respiratory and Environmental Workgroup (CREW)
-
批准号:9262672
-
项目类别:
-
资助金额:$167.98万
-
财政年份:2016
-
负责人:James E. Gern
-
依托单位:
Children's Respiratory and Environmental Workgroup (CREW)
-
批准号:10011947
-
项目类别:
-
资助金额:$1141.82万
-
财政年份:2016
-
负责人:James E. Gern
-
依托单位:
Children's Respiratory and Environmental Workgroup (CREW)
-
批准号:10475195
-
项目类别:
-
资助金额:$1287.16万
-
财政年份:2016
-
负责人:James E. Gern
-
依托单位:
Children's Respiratory and Environmental Workgroup (CREW)
-
批准号:10241271
-
项目类别:
-
资助金额:$1337.16万
-
财政年份:2016
-
负责人:James E. Gern
-
依托单位:
Inner City Asthma consortium 3 (ICAC3)
-
批准号:9755346
-
项目类别:
-
资助金额:$1120.62万
-
财政年份:2014
-
负责人:James E. Gern
-
依托单位:
Inner City Asthma consortium 3 (ICAC3)
-
批准号:10217307
-
项目类别:
-
资助金额:$43.84万
-
财政年份:2014
-
负责人:James E. Gern
-
依托单位:
Wisconsin Infant Study Cohort (WISC)
-
批准号:10440066
-
项目类别:
-
资助金额:$82.75万
-
财政年份:2013
-
负责人:James E. Gern
-
依托单位:
Mechanisms and Enviromental Determinants of Rhinovirus Illness Severity
-
批准号:8465479
-
项目类别:
-
资助金额:$147.95万
-
财政年份:2013
-
负责人:James E. Gern
-
依托单位:
Administrative Core
-
批准号:10634245
-
项目类别:
-
资助金额:$6.91万
-
财政年份:2013
-
负责人:James E. Gern
-
依托单位:
Viral and Environmental Determinants of Rhinovirus Illness Severity
-
批准号:10327675
-
项目类别:
-
资助金额:$133.87万
-
财政年份:2013
-
负责人:James E. Gern
-
依托单位:
Administrative Core
-
批准号:10440064
-
项目类别:
-
资助金额:$3.46万
-
财政年份:2013
-
负责人:James E. Gern
-
依托单位:
Project 3: Interactions between microbial metabolites, airway pathogens and airway epithelial cell function
-
批准号:10634248
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2013
-
负责人:James E. Gern
-
依托单位:
海外基金